Qatar says US-Iran talks have made ‘positive progress’
Qatar’s Foreign Ministry spokesperson said that “positive progress” was made on issues related to the Memorandum of Understanding (MoU) following separate meeting of Qatari and Pakistani mediators with the US and Iranian delegation in Doha, CNN reported on Wednesday.
The Qatari government spokesperson said that US President Donald Trump’s son-in-law Jared Kushner and US special envoy Steve Witkoff arrived in Doha, Qatar on Tuesday for indirect talks with Iran. The US envoys are speaking with mediators and not directly with the Iranians.
In Washington, Trump described the meetings in Doha as very good. "As far as things are going, the denuclearization of Iran is moving along well," Trump told reporters. “They’ve had very good meetings and we’ll see,” he added.
However, the source stated that the nuclear program did not come up in the talks, which were technical in nature. Qatar's Foreign Ministry said that the next meeting will take place after funeral processions for Iran's late Supreme Leader Ayatollah Ali Khamenei, who is due to be buried on July 9.
Market reaction
At press time, the WTI Oil price trades 2.80% lower at around $67.97.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The "Outlier" Investment Art in the New Era of Berky
Chevron (CVX.US) explores alternative hedging for Middle East supply disruptions: targets Argentina and the Mediterranean to drive global LNG growth, seeks deal with India
Chevron is focusing on Argentina and the Mediterranean region, seeking global growth in liquefied natural gas, and plans to reach an agreement with India.
Energy and food price pressures intensify, potentially triggering an inflation rebound! The Bank of England may struggle to remain "calm" as market rate hike bets surge
The upward pressure on energy prices caused by the unresolved Middle East war is mounting. New risks are also approaching, which may keep inflation above the Bank of England’s 2% target for most of next year.
AstraZeneca (AZN.US) Breast Cancer Drug Etcamah Faces Setback in Phase III Clinical Trial, Potentially Impacting Billions in Sales
Bloomberg Intelligence analyst John Murphy stated that the setback in AstraZeneca's breast cancer drug trial could reduce sales in 2035 by $2.6 billion to $3.8 billion.
Crypto prices
More
